Jia Li Low

Low‐dose pembrolizumab in the treatment of advanced non‐small cell lung cancer

Jia Li Low, Yiqing Huang, Kenneth Sooi et al. · International Journal of Cancer · 2021 · 53 citations · Full text

Surgical Oncology, Cancer Management, Pharmacotherapy +19

Real‐world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage <scp>III</scp> non‐small cell lung cancer

Yiqing Huang, Joseph J. Zhao, Yu Yang Soon et al. · Thoracic Cancer · 2022 · 29 citations · Full text

Immune checkpoint inhibition for non-small cell lung cancer in patients with pulmonary tuberculosis or Hepatitis B: Experience from a single Asian centre

Gloria HJ Chan, Yong Xiang Gwee, Jia Li Low et al. · Lung Cancer · 2020 · 28 citations

Single Asian Centre, Pulmonary Tuberculosis, Cancer Immunosurveillance +12

Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience

Joseph J. Zhao, Nesaretnam Barr Kumarakulasinghe, Vaishnavi Muthu et al. · Oncology · 2021 · 25 citations

Real-world outcomes from use of CDK4/6 inhibitors in the management of advanced/metastatic breast cancer in Asia

Jia Li Low, Elaine Hsuen Lim, Lavina Bharwani et al. · Therapeutic Advances in Medical Oncology · 2022 · 19 citations · Full text